Clinical Trial Update: An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Termination of a Phase 1/2 open-label trial evaluating mosunetuzumab in combination with tiragolumab, with or without atezolizumab, in B-cell non-Hodgkin lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• LUNSUMIO (mosunetuzumab)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Hodgkin Lymphoma, Follicular Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-10-04